Literature DB >> 27049264

MicroRNA-138 inhibits proliferation of cervical cancer cells by targeting c-Met.

B Li1, X-X Yang, D Wang, H-K Ji.   

Abstract

OBJECTIVE: MicroRNAs (miRNAs) function as important post-transcriptional regulators involved in a wide range of biological behaviors. MicroRNA-138 (miR-138) has been shown to play a critical role in tumor pathogenesis, the present study aimed to investigate the role of miR-138 in cervical cancer.
MATERIALS AND METHODS: CCK-8 assay was performed to measure the viabilities of cancer cells. Quantitative real-time PCR (qRT-PCR) and western blot were used to detect the mRNA and protein expression, respectively. Moreover, the miRNA target genes were validated with luciferase activity assay.
RESULTS: In the current study, we found that the expression of miR-138 was significantly down-regulated in cervical cancer tissues compared to the adjacent non-cancer tissues. CCK-8 assay showed that over-expression of miR-138 suppressed the proliferation of four cervical cancer cell lines including HeLa, SiHa, C33A and CaSki. By contrast, down-regulation of miR-138 promoted the growth of cervical cancer cells. In addition, increased expression of miR-138 led to a reduction in c-Met expression, whereas inhibition of miR-138 enhanced c-Met levels in cervical cancer cells. The luciferase reporter assay showed that c-Met was a direct target of miR-138 in cervical cancer cells.
CONCLUSIONS: These findings demonstrated that miR-138 inhibited cervical cancer cells proliferation via c-Met, providing a novel target for the molecular treatment of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27049264

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  14 in total

1.  MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.

Authors:  Yue Zhao; Zhongshi Xie; Jie Lin; Peng Liu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

Review 2.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

3.  Long non-coding RNA BCYRN1 promotes the proliferation and metastasis of cervical cancer via targeting microRNA-138 in vitro and in vivo.

Authors:  Jie Peng; Fang Hou; Jun Feng; Shui-Xian Xu; Xiao-Yan Meng
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

4.  miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma.

Authors:  Zhenwei Qiu; Hai Li; Jianwei Wang; Chongbing Sun
Journal:  Oncol Rep       Date:  2017-09-25       Impact factor: 3.906

5.  miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.

Authors:  Zaiting Ye; Bingmu Fang; Jiongwei Pan; Ning Zhang; Jinwei Huang; Congying Xie; Tianzheng Lou; Zhuo Cao
Journal:  Oncol Rep       Date:  2017-05-03       Impact factor: 3.906

6.  Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice.

Authors:  Alberto Izzotti; Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Mariagrazia Longobardi; Alessandra Pulliero; Marta Geretto; Rosanna T Micale; Sebastiano La Maestra; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Oncotarget       Date:  2016-12-20

7.  MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met.

Authors:  Yan Guo; Min Tao; Min Jiang
Journal:  Exp Ther Med       Date:  2018-01-08       Impact factor: 2.447

8.  Cigarette smoke enhances oncogene addiction to c-MET and desensitizes EGFR-expressing non-small cell lung cancer to EGFR TKIs.

Authors:  Chih-Yen Tu; Fang-Ju Cheng; Chuan-Mu Chen; Shu-Ling Wang; Yu-Chun Hsiao; Chia-Hung Chen; Te-Chun Hsia; Yu-Hao He; Bo-Wei Wang; I-Shan Hsieh; Yi-Lun Yeh; Chih-Hsin Tang; Yun-Ju Chen; Wei-Chien Huang
Journal:  Mol Oncol       Date:  2018-04-14       Impact factor: 6.603

9.  MicroRNA-138 directly targets TNFAIP8 and acts as a tumor suppressor in osteosarcoma.

Authors:  Zheng Zhou; Zhihong Li; Yi Shen; Tao Chen
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

10.  MicroRNA-138 suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting EZH2 and PI3K/AKT signaling.

Authors:  Fengzhi Si; Jie Sun; Chunli Wang
Journal:  Exp Ther Med       Date:  2017-07-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.